Bioharvest Sciences (BHST) Operating Leases (2023 - 2025)

Bioharvest Sciences has reported Operating Leases over the past 3 years, most recently at $1.4 million for Q4 2025.

  • Quarterly results put Operating Leases at $1.4 million for Q4 2025, up 81.99% from a year ago — trailing twelve months through Dec 2025 was $1.4 million (up 81.99% YoY), and the annual figure for FY2025 was $1.4 million, up 81.99%.
  • Operating Leases for Q4 2025 was $1.4 million at Bioharvest Sciences, up from $772000.0 in the prior quarter.
  • Over the last five years, Operating Leases for BHST hit a ceiling of $1.7 million in Q4 2023 and a floor of $772000.0 in Q4 2024.
  • Median Operating Leases over the past 3 years was $1.4 million (2025), compared with a mean of $1.3 million.
  • Biggest five-year swings in Operating Leases: plummeted 55.56% in 2024 and later soared 81.99% in 2025.
  • Bioharvest Sciences' Operating Leases stood at $1.7 million in 2023, then plummeted by 55.56% to $772000.0 in 2024, then soared by 81.99% to $1.4 million in 2025.
  • The last three reported values for Operating Leases were $1.4 million (Q4 2025), $772000.0 (Q4 2024), and $1.7 million (Q4 2023) per Business Quant data.